This NDC is on FDA's drug shortage list (posted Mar 26, 2018)

Reported reason: Other

Product Information

KETOROLAC 30 MG/ML VIAL is a generic product labeled by Hospira Inc., priced at $1.0046 per ML under NDC 00409379501. Its NADAC has been published 637 times since Nov 28, 2013.

FDA first approved this application on Jun 5, 1997. Its Orange Book therapeutic-equivalence code is AP.

KETOROLAC 30 MG/ML VIAL

KETOROLAC TROMETHAMINE
$1.0046per ML

Strength

30 mg/mL

Manufacturer

Hospira Inc.

NDC

00409379501

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA074802

FDA Approved

6/5/1997

TE Code

AP

On Market Since

1/19/2006

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 30 MG/ML VIAL has been published 637 times since Nov 28, 2013, and over the history we have for it it has risen 27.3%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0046 per ML
All-time high$4.4589 (Nov 16, 2016)
All-time low$0.6711 (Aug 20, 2014)
52-week high$1.0448
52-week low$0.7047
Median price$1.3894
Average price$1.6363
Largest weekly change+94.7% (Aug 17, 2016)
Weeks tracked637
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-1.3%

3M

-0.1%

6M

+36.0%

1Y

+8.3%

3Y

-32.3%

5Y

-23.9%

All

+27.3%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 30 MG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 30 MG/ML VIAL, manufactured by Hospira Inc., is $1.0046 per ML (NDC 00409379501), effective Nov 11, 2026.

How has the price of KETOROLAC 30 MG/ML VIAL changed over time?

Over the history we have for it, the NADAC for KETOROLAC 30 MG/ML VIAL has risen 27.3%. It has been tracked across 637 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for KETOROLAC 30 MG/ML VIAL?

Since Nov 28, 2013, the NADAC for KETOROLAC 30 MG/ML VIAL has ranged from a low of $0.6711 (Aug 20, 2014) to a high of $4.4589 (Nov 16, 2016), with a median of $1.3894 per ML.

Are there cheaper alternatives to KETOROLAC 30 MG/ML VIAL?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.6167 per ML — about 39% below KETOROLAC 30 MG/ML VIAL.

Who manufactures KETOROLAC 30 MG/ML VIAL?

KETOROLAC 30 MG/ML VIAL (NDC 00409379501) is labeled by Hospira Inc., and CMS classifies it as a generic product.

Is KETOROLAC 30 MG/ML VIAL in shortage?

Yes — NDC 00409379501 is currently listed in FDA's drug shortage database (posted Mar 26, 2018). Reported reason: Other.